Wound Care Market Analysis

Functions (Hospitals, Specialty Clinics, Home Healthcare)

The segment is set to have a substantial market share of 35% in 2037. This can be accredited to the large number of patients requiring advanced wound care and hospitalized for surgery or treatment of chronic conditions such as diabetes and pressure ulcers. The hospital also has the wound care management devices and staff necessary for advanced wound care, including growth factor therapy and negative pressure wound therapy (NPWT).

Applications (Chronic Wounds, Acute Wounds)

In the year 2037, the chronic wounds segment in the wound care market is predicted to command a large proportion of over 60%. The segment's expansion can be attributed to the rising prevalence of chronic wounds such as diabetes, pressure ulcers, and other disorders. In the year 2018, the incidence of chronic ulcers was over 2 per 1000 population and the incidence of chronic leg ulcers was 1 per 1000 population. Chronic wounds can be defined as physiologically compromised wounds resulting from disruption of the wound healing cycle as a result of impaired angiogenesis, innervation, or cell migration, among others. Normal wound healing is discussed separately. Skin wounds that do not heal, heal slowly, or heal but tend to recur are called chronic wounds. Many causes of chronic (permanent) skin wounds may include trauma, burns, skin cancer, infections, or underlying conditions such as diabetes. Wounds that take a long time to heal require special care.

Our in-depth analysis of the global market includes the following segments: